COVID-19 Updates: State of public health emergency declared.
This release was issued under a previous government.
Fourteen of those 15 deaths occurred between September and the end of November.
“I am deeply concerned about the increasing number of deaths associated with carfentanil. It’s possible these individuals were not aware they were taking it. Albertans need to know that carfentanil is here – in Alberta cities and towns – and that it’s an extremely dangerous and deadly opioid. Even the smallest trace can be lethal.”
“The increasing number of deaths due to this dangerous drug is concerning to us, and we will continue to work closely with our health partners, as part of sharing information and raising awareness of opioids misuse. The Alberta Office of the Chief Medical Examiner is one of only a very small number of toxicology laboratories in Canada that is able to positively identify carfentanil in human blood.”
Alberta remains focused on harm reduction as it moves forward with a co-ordinated and collaborative provincial response to the opioid crisis.
When combined with prevention, treatment and enforcement, a broad spectrum of harm reduction approaches will help decrease harmful consequences of drug use to keep people alive.
If you are using these types of drugs:
- Don’t use them alone and make sure you are near someone who can call for help.
- Don’t mix them with other drugs or alcohol.
- It you suspect someone is overdosing, don’t wait. Dial 911 right away.
- Carry a naloxone kit. Know how to use it to save someone’s life. Make sure your buddy knows how to use it to save yours. Naloxone is a temporary fix – you still need to call 911.
- Most importantly, know there are resources available to help you whether you are using drugs for the first time or have used them frequently.
- If you’re concerned about your own or someone else’s use of illicit drugs, call the Addiction Helpline (24 hours a day, seven days a week) at 1-866-332-2322, or Health Link at 811.
Provincial response to opioid crisis
- Working closely with other Alberta government ministries, health experts, community groups, parent advocates, law enforcement and the medical community, the Chief Medical Officer of Health is leading a collaborative and co-ordinated provincial response, focused on four key areas:
- Improving the collection and publishing of data to better target interventions
- Expanding access to opioid replacement therapy.
- Funding community agencies to assess the need for supervised consumption services.
- Promoting appropriate opioid prescribing and implementing new tools to prevent prescription drug misuse, in partnership with the College of Physicians and Surgeons of Alberta.
- Publicly funded take-home naloxone kits are available at more than 900 registered sites, including community pharmacies.
- A new public awareness social-media campaign has been rolled out. It explains how to use naloxone to prevent overdose deaths and on where people can get naloxone free of charge.
- Grant funding is being provided to Access to Medically Supervised Injection Services Edmonton to support community engagement and the development of an application for a federal exemption to offer supervised consumption services in Edmonton’s inner city.
- The province has invested $3 million over the next three years for an opioid dependency treatment (ODT) expansion project. Work is under way to increase access to opioid replacement therapy in Alberta Health Services ODT clinics.
- The province has provided “Proceeds of Crime” grants totalling $240,000 to police and their community partners to raise awareness of the dangers of fentanyl and other illicit drugs.
- Legislation will come into effect in January 2017 to regulate pill presses to enhance enforcement for illicit fentanyl manufacturing.